학술논문
Discovery and Preclinical Characterization of BIIB091, a Reversible, Selective BTK Inhibitor for the Treatment of Multiple Sclerosis
Document Type
Article
Author
Hopkins, B.T.; Bame, E.; Bajrami, B.; Black, C.; Bohnert, T.; Boiselle, C.; Burdette, D.; Burns, J.C.; Delva, L.; Donaldson, D.; Grater, R.; Gu, C.; Hoemberger, M.; Johnson, J.; Kapadnis, S.; King, K.; Lulla, M.; Ma, B.; Marx, I.; Magee, T.; Meissner, R.; Metrick, C.M.; Mingueneau, M.; Murugan, P.; Otipoby, K.L.; Polack, E.; Poreci, U.; Prince, R.; Roach, A.M.; Rowbottom, C.; Santoro, J.C.; Schroeder, P.; Tang, H.; Tien, E.; Zhang, F.; Lyssikatos, J.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 27 January 2022, 65(2):1206-1224)
Subject
Language
English
ISSN
15204804
00222623
00222623